Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 4
2005 4
2006 3
2007 3
2008 3
2009 2
2010 1
2011 4
2012 6
2013 4
2014 3
2015 8
2016 5
2017 8
2018 5
2019 8
2020 3
2021 10
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Nakamori M, Nakatani D, Sato T, Hasuike Y, Kon S, Saito T, Nakamura H, Takahashi MP, Hida E, Komaki H, Matsumura T, Takada H, Mochizuki H. Nakamori M, et al. Among authors: saito t. EClinicalMedicine. 2023 Dec 26;67:102390. doi: 10.1016/j.eclinm.2023.102390. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38314057 Free PMC article.
The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
Muntoni F, Byrne BJ, McMillan HJ, Ryan MM, Wong BL, Dukart J, Bansal A, Cosson V, Dreghici R, Guridi M, Rabbia M, Staunton H, Tirucherai GS, Yen K, Yuan X, Wagner KR; Taldefgrobep Alfa Study Group. Muntoni F, et al. Neurol Ther. 2024 Feb;13(1):183-219. doi: 10.1007/s40120-023-00570-w. Epub 2024 Jan 8. Neurol Ther. 2024. PMID: 38190001 Free PMC article.
[Questionnaire for Kinki area Japanese Society of Neurology board members regarding transitional medicine for neurological disease patients].
Saito T, Koda T, Okuno T, Ikeda A, Mochizuki H; Special Committee for Measures Against Transition from Pediatric to Adult Health Care, Japanese Society of Neurology. Saito T, et al. Rinsho Shinkeigaku. 2023 Sep 20;63(9):559-565. doi: 10.5692/clinicalneurol.cn-001884. Epub 2023 Aug 29. Rinsho Shinkeigaku. 2023. PMID: 37648474 Japanese.
Correction: Noguchi et al. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Genes 2022, 13, 2110.
Noguchi Y, Bo R, Nishio H, Matsumoto H, Matsui K, Yano Y, Sugawara M, Ueda G, Wijaya YOS, Niba ETE, Shinohara M, Bouike Y, Takeuchi A, Okamoto K, Saito T, Shimomura H, Lee T, Takeshima Y, Iijima K, Nozu K, Awano H. Noguchi Y, et al. Among authors: saito t. Genes (Basel). 2023 Mar 21;14(3):759. doi: 10.3390/genes14030759. Genes (Basel). 2023. PMID: 36981045 Free PMC article.
[Current practices of transition from pediatric to adult health care for patients with neurological disease: promote the cooperation between child and adult neurologists].
Mochizuki Y, Ogata K, Kumada S, Suzuki Y, Ichinose H, Sakiyama Y, Saito T, Mochizuki H; Special Committee on Measures for Transition from Pediatric to Adult Health Care, the Japanese Society of Neurology. Mochizuki Y, et al. Among authors: saito t. Rinsho Shinkeigaku. 2023 Feb 25;63(2):67-72. doi: 10.5692/clinicalneurol.cn-001815. Epub 2023 Jan 31. Rinsho Shinkeigaku. 2023. PMID: 36725009 Japanese.
PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
Noguchi Y, Bo R, Nishio H, Matsumoto H, Matsui K, Yano Y, Sugawara M, Ueda G, Wijaya YOS, Niba ETE, Shinohara M, Bouike Y, Takeuchi A, Okamoto K, Saito T, Shimomura H, Lee T, Takeshima Y, Iijima K, Nozu K, Awano H. Noguchi Y, et al. Among authors: saito t. Genes (Basel). 2022 Nov 14;13(11):2110. doi: 10.3390/genes13112110. Genes (Basel). 2022. PMID: 36421785 Free PMC article.
97 results